Navigation Links
NUCRYST Pharmaceuticals announces year-end results
Date:2/14/2008

currency

translation

adjustments - - - (209)

Net loss - - - -

-------------------------------------------------------------------------

December 31, 2006 18,309,613 82,672 482 (5,490) (34,078)

Issuance of common

shares in connection

with restricted

shares and exercises

of stock options 57,950 104 - -

Stock-based

compensation - - 1,029 -

Foreign currency

translation

adjustments - - - 6,047

Net loss - - - -

-------------------------------------------------------------------------

December 31, 2007 18,367,563 $ 82,776 $ 1,511 $ 557

-------------------------------------------------------------------------

-------------------------------------------------------------------------

-------------------------------------------------------------

(thousands of Total Total

U.S. dollars, Accumulated Comprehensive Shareholders'

except share data) Deficit Loss Equity

-------------------------------------------------------------

December 31, 2005 (23,579) (3,742) 13,769

Issuance of common

shares upon

conversion of

indebtedness to

related party

(note 9) - - 39,642

Issuance of common

shares in connection

with restricted

shares and exercises

of stock options

and share

appreciation rights - - 401

Stock-based

compensation - -
'/>"/>

SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. NUCRYST Pharmaceuticals announces 2007 third quarter results
2. Webcast Advisory - NUCRYST Pharmaceuticals Webcast of Conference Call to Discuss 2007 Third Quarter Results
3. NUCRYST and Smith & Nephew Revise Agreements
4. Renhuang Pharmaceuticals, Inc. Retains CCG Elite
5. MiddleBrook Pharmaceuticals Engages Morgan Stanley in Its Strategic Process
6. Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities
7. American Association of Clinical Endocrinologists and North American Menopause Society Fail to Disclose Financial Ties to Wyeth Pharmaceuticals
8. MedThink Communications Selected by Salix Pharmaceuticals to Launch New Product
9. Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program
10. Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer
11. Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Norton HealthDay Reporter MONDAY, ... better when newborn intensive care units (NICU) set up private ... new study finds. Researchers at one children,s hospital found ... less distressed when their NICU switched from the traditional "open-bay" ... online Sept. 22 in the journal Pediatrics , add ...
(Date:9/22/2014)... Malaysia today became a founding partner in the Global ... to promoting young talent in science, technology, engineering and ... New York Academy of Sciences (NYAS), Malaysian Prime Minister ... Monday Sept. 22. , With the goal of developing ... countries by 2020, the initiative will create a host ...
(Date:9/22/2014)... two-generation approaches to reducing poverty that help children ... researchers, advocates, and foundations. By combining education and ... to jobs that offer a path out of ... children, these programs aim to improve the life ... new report from the National Center for Children ...
(Date:9/22/2014)... York, New York (PRWEB) September 22, 2014 ... associated with the use of power morcellators ( ... LLP notes a new report detailing the continued ... warnings from federal regulators that specifically discouraged these ... physicians believe that the potential cancer risks associated ...
(Date:9/22/2014)... Pain does not need to rule your life anymore! ... book designed to guide the individual who suffers with chronic ... is written to help the reader who is struggling with ... a pain-free life — a daily “go-to” guide on breaking ... has become an epidemic, with over 100 million Americans suffering ...
Breaking Medicine News(10 mins):Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3Health News:A two-generation lens: Current state policies fail to support families with young children 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 4Health News:Naturopathic Doctor Inspires and Guides Those Who Suffer with Chronic Pain, Pointing the Way Back to Pain-free Living 2
... significantly reduce demand? A new study suggests it will. ... of one side of a cigarette pack with a text ... labels, which include graphic images of lung and mouth cancer, ... 404 adult smokers from four states participated in an experimental ...
... Gordon HealthDay Reporter , MONDAY, Aug. 8 (HealthDay ... at home may reach unsafe temperatures by the time a ... in an insulated container with ice packs. A new ... of the food sent from home was at an unsafe ...
... Aug. 8 (HealthDay News) -- Youth sports programs need ... illness, says an updated policy statement from the American ... can safely participate in outdoor sports and activities in ... adults sometimes create situations that are potentially dangerous," Dr. ...
... prostate cancer expect better recovery from the side effects of ... operation, a University of Michigan Comprehensive Cancer Center study finds. ... of men had expected to have better urinary continence and ... before it the exact opposite of what typically happens. ...
... may not be enough to treat symptoms in neonates ... study from Nationwide Children,s Hospital, this is the first ... neonates based on how and what is refluxed. ... in infants at risk of the life-threatening events chronic ...
... the latest issue of Nature , researchers at ... Pennsylvania clarify the role of two proteins key to ... Notch passes off much of its role during T-cell ... required for many aspects of immunity, and understanding how ...
Cached Medicine News:Health News:Study: Graphic warning labels reduce demand for cigarettes 2Health News:Are Kids Brown-Bagging Bacteria? 2Health News:Are Kids Brown-Bagging Bacteria? 3Health News:Kids Can Safely Play Sports in Hot Weather: Experts 2Health News:Men have overly optimistic expectations about recovery from prostate cancer surgery, U-M study finds 2Health News:New study helps clarify symptoms and characteristics of acid reflux in neonates 2Health News:Penn researchers describe key molecule that keeps immune cell development on track 2
(Date:9/22/2014)... 22, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... a phase I clinical trial in patients with ... tolerability, and immunogenicity of INO-3106. This immunotherapy targets ... aerodigestive cancers. Aerodigestive cancers affect the ... parts of the esophagus and windpipe. The unmet ...
(Date:9/22/2014)... 2014  CorMedix Inc. (NYSE MKT: CRMD), a ... products for the prevention and treatment of cardiorenal ... that TUV-SUD and The Medicinal Evaluation Board of ... granted its request for a label expansion for ... approved in July 2013 for use in the ...
(Date:9/22/2014)... , Sept. 22, 2014  Seres Health, a ... to the human microbiome, today announced that it has ... 2014,s Fierce 15 biotechnology companies, designating it as one ... industry.  "Amid a great deal of ... its focus and commitment to practical therapeutic development," says ...
Breaking Medicine Technology:Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4Neutrolin Label Expansion Approved for the European Union 2Neutrolin Label Expansion Approved for the European Union 3Seres Health Named a "Fierce 15" Biotech Company for 2014 2
... Jenner Stain is used for staining ... one of the oldest stain formulations ... results similar to that of Giemsa ... appear brighter red; basophilic granules and ...
... Our Buffered Wright-Giemsa Stain ... that contains the fixative, buffer, ... convenient staining of blood smears. ... 32-oz. bottle for ease of ...
RABIT (Rapid Automated Bacterial Impedance Technique) has been developed by Don Whitley Scientific over several years with the aid of leading product and computer design consultants....
For the quantitative determination of Albumin in serum. Endpoint procedure with Amax at 630 nm. Linearity: to 6 g/dl. Liquid ready-to-use reagent....
Medicine Products: